Promising new data demonstrate that a novel pain therapy system manages patients with chronic neuropathic pain
16 May 2013 | By Biosector 2
Spinal Modulation Inc. designed the Axium™ Spinal Cord Stimulator System...
List view / Grid view
News
Roche’s obinutuzumab significantly reduced the risk of disease progression or death in people with one of the most common forms of blood cancer
16 May 2013 | By Roche
First results from CLL11 announced...
AstraZeneca issues update on accelerated oncology pipeline in advance of 2013 ASCO Annual Meeting
16 May 2013 | By AstraZeneca
First patient enrolled in Phase III clinical trial...
Biogen Idec Foundation awards $250,000 to East End House to develop genetics education program
16 May 2013 | By Biogen Idec
“Biogen Idec Foundation & East End House share an ongoing commitment..."
Gilead announces response data from Phase 2 study of idelalisib for previously untreated CLL
15 May 2013 | By Gilead Sciences
Gilead Sciences, Inc. announced results from a Phase 2 study...
Astellas to restructure, close some research units
15 May 2013 | By Astellas
Astellas Pharma announces plans to reshape its research framework to further enhance the ability to generate innovative drugs...
FDA approves Tarceva (Erlotinib) tablets for specific type of lung cancer
15 May 2013 | By Astellas Pharma Inc.
The FDA also approved the cobas® EGFR Mutation Test, which was developed by Roche and validated in the pivotal EURTAC study...
Roche to present important new data reflecting broad cancer pipeline at ASCO
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
Sanofi and Regeneron announce patient enrollment in two Phase 3 trials with sarilumab in RA
15 May 2013 | By Sanofi
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials...
Lonza launches 2013-2014 BioResearch Catalog
Diabetes prevention has become a key focus area for the drug development market.
Ranbaxy announces conclusion of previously disclosed investigation by U.S Department of Justice
13 May 2013 | By DAIICHI SANKYO COMPANY, LIMITED
"Today’s announcement marks the resolution of this past issue..."
U.S. FDA grants Priority Review to simeprevir for combination treatment of genotype 1 chronic hepatitis C
13 May 2013 | By Johnson & Johnson
The U.S. FDA has granted Priority Review to the NDA for simeprevir (TMC435)...
FDA accepts Biogen Idec’s BLA for first long-lasting factor VIII therapy for hemophilia A
13 May 2013 | By Biogen Idec
The U.S. FDA has accepted BLA for the marketing approval of ELOCTATE™...
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
10 May 2013 | By GlaxoSmithKline
GlaxoSmithKline and Theravance announced that the US FDA has approved BREO™ ELLIPTA™...
Novartis drug Ilaris® approved by FDA
10 May 2013 | By Novartis
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab)...
